Delivery Order SPE2DB22D3010-SPE2DB24FP2YW

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $1,265.76. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Albendazole 200 mg tablets. The contract has a period of performance through September 25, 2024 and is a firm fixed price agreement. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albendazole 200 mg tablets. The contract, valued at $1,997.46, has a performance period through January 16, 2025 and was awarded on a Firm Fixed Price basis. This Delivery Order contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $6,560.39, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,688,675 units of Albendazole 200 mg tablets, with a completion date of December 12, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,094.03 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,356,680 units of Albendazole 200 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,875.00 delivery order contract is for the supply of 4,563,057,206 units of Albendazole 200 mg tablets. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Albendazole 200 mg tablets. The contract has a ceiling value of $6,056.65 and was awarded on September 17, 2024, with a completion date of September 18, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp is for the delivery of 4561569107 Albendazole 200mg tablets. The single-award delivery order contract has a firm fixed price of $1,839.01 and an ultimate completion date of July 24, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies medical products to federal government agencies, particularly...
This federal contract award, valued at $3,814.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albendazole 200 mg tablets to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,213.30, is for the delivery of 4,566,709,129 tablets of Albendazole 200 mg, a medication used to treat certain parasitic infections. The contract is a firm fixed-price delivery order, with a completion date of December 13, 2024. This award is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $20,346.64 and is for the delivery of ALBENDAZOLE 200 MG TABLET 2S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP2YW
    Delivery Order

This federal contract award, valued at $1,196.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Albendazole 200 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation and will be completed by August 2, 2024. Amerisourcebergen's federal contracting activities focus on supplying essential pharmaceutical and medical products to various government agencies and healthcare programs, including the military, veterans' hospitals, and other federal providers.

Generated 10/31/24, 9:07 AM